dieckol and Non-alcoholic-Fatty-Liver-Disease

dieckol has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 2 studies

Other Studies

2 other study(ies) available for dieckol and Non-alcoholic-Fatty-Liver-Disease

ArticleYear
Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice.
    Marine drugs, 2021, Aug-30, Volume: 19, Issue:9

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aquatic Organisms; Benzofurans; Diet, High-Fat; Disease Models, Animal; Energy Intake; Liver; Lymphatic Vessels; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phaeophyceae; Plant Extracts

2021
Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis.
    Marine drugs, 2021, May-30, Volume: 19, Issue:6

    Topics: Animals; Benzofurans; Carnitine O-Palmitoyltransferase; Diet, High-Fat; Gene Expression; HMGB1 Protein; Inflammasomes; Lipase; Lipolysis; Liver; Male; Mice, Inbred C57BL; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; PPAR alpha; Pyroptosis; Toll-Like Receptor 4

2021